ICL Group
ICL
5.08
0.00
0.00%
ICL Group
US · ICL
#1851 by market cap
Listed 1970
5.08
0.00
0.00%
Live - 5344 symbols - heartbeat 444s ago
· 2026-10-08 07:33
Pre-market
5.00
-1.58%
After-hours
5.08
0.00%
Overnight
5.07
-0.20%
- Market cap
- 6.56B
- P/E (TTM)i
- 21.17
- P/Bi
- 1.07
- EPSi
- 0.18
- Div yieldi
- 3.76%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on ICL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.15, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.56% YoY
Margins
- Gross margin
- 30.56%
- Operating margin
- 9.62%
- Net margin
- 3.16%
Key ratios & quality
- Enterprise valuei
- 8.64B
- Altman Z-Scorei
- 2.15
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.56B | 5.27B | 5.04B | 6.96B | 10.02B | 7.54B | 6.84B | 7.15B |
| Gross profit | 1.85B | 1.82B | 1.49B | 2.61B | 5.03B | 2.67B | 2.26B | 2.19B |
| Selling & admin expenses | 1.06B | 1.02B | 1.07B | 1.33B | 1.47B | 1.35B | 1.37B | 1.41B |
| Research & development | 55.00M | 50.00M | 54.00M | 64.00M | 68.00M | 71.00M | 69.00M | 70.00M |
| Operating profit | 744.00M | 748.00M | 292.00M | 1.21B | 3.49B | 1.25B | 802.00M | 688.00M |
| Pretax profit | 1.36B | 628.00M | 49.00M | 1.09B | 3.40B | 974.00M | 636.00M | 441.00M |
| Tax | 129.00M | 147.00M | 25.00M | 260.00M | 1.19B | 287.00M | 172.00M | 161.00M |
| Net profit | 1.24B | 481.00M | 24.00M | 832.00M | 2.22B | 687.00M | 464.00M | 280.00M |
| Basic EPS | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 |
| Diluted EPS | 0.97 | 0.37 | 0.01 | 0.60 | 1.67 | 0.50 | 0.32 | 0.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.77B | 1.83B | 1.85B | 1.70B | 2.02B | 2.14B |
| Gross profit | 560.00M | 554.00M | 604.00M | 468.00M | 626.00M | 664.00M |
| Selling & admin expenses | 345.00M | 346.00M | 363.00M | 359.00M | 377.00M | 383.00M |
| Research & development | 18.00M | 19.00M | 16.00M | 17.00M | 15.00M | 14.00M |
| Operating profit | 197.00M | 189.00M | 225.00M | 77.00M | 234.00M | 267.00M |
| Pretax profit | 148.00M | 168.00M | 186.00M | -61.00M | 193.00M | 224.00M |
| Tax | 42.00M | 60.00M | 57.00M | 2.00M | 53.00M | 72.00M |
| Net profit | 106.00M | 108.00M | 129.00M | -63.00M | 140.00M | 152.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.07 | 0.07 | 0.09 | -0.06 | 0.10 | 0.11 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.79B | 2.68B | 2.84B | 3.91B | 4.55B | 4.03B | 3.59B | 4.16B |
| Cash & ST investments | 213.00M | 298.00M | 433.00M | 564.00M | 508.00M | 592.00M | 442.00M | 496.00M |
| Inventory | 1.29B | 1.31B | 1.25B | 1.57B | 2.13B | 1.70B | 1.63B | 1.93B |
| Total assets | 8.78B | 9.17B | 9.66B | 11.08B | 11.75B | 11.63B | 11.32B | 12.41B |
| Total current liabilities | 2.01B | 1.76B | 2.18B | 2.61B | 2.61B | 2.64B | 2.33B | 3.13B |
| Short-term debt | 610.00M | 420.00M | 679.00M | 577.00M | 512.00M | 858.00M | 384.00M | 876.00M |
| Long-term debt | 1.82B | 1.93B | 1.79B | 2.20B | 2.11B | 1.63B | 1.72B | 1.70B |
| Total liabilities | 4,861,000,000.00 | 5,112,000,000.00 | 5,576,000,000.00 | 6,344,000,000.00 | 6,037,000,000.00 | 5,590,000,000.00 | 5,334,000,000.00 | 6,170,000,000.00 |
| Total equity | 3.92B | 4.06B | 4.09B | 4.74B | 5.71B | 6.04B | 5.99B | 6.24B |
| Retained earnings | 3.74B | 3.88B | 3.75B | 4.32B | 5.39B | 5.58B | 5.76B | 5.77B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.84B | 4.24B | 4.05B | 4.16B | 4.45B | 4.50B |
| Cash & ST investments | 433.00M | 701.00M | 476.00M | 496.00M | 581.00M | 662.00M |
| Inventory | 1.63B | 1.69B | 1.78B | 1.93B | 1.87B | 1.83B |
| Total assets | 11.69B | 12.38B | 12.26B | 12.41B | 13.01B | 13.19B |
| Total current liabilities | 2.60B | 2.43B | 2.82B | 3.13B | 3.24B | 2.84B |
| Short-term debt | 570.00M | 365.00M | 787.00M | 876.00M | 926.00M | 646.00M |
| Long-term debt | 1.86B | 2.55B | 1.89B | 1.70B | 2.22B | 2.65B |
| Total liabilities | 5,568,000,000.00 | 6,107,000,000.00 | 5,881,000,000.00 | 6,170,000,000.00 | 6,684,000,000.00 | 6,745,000,000.00 |
| Total equity | 6.12B | 6.27B | 6.38B | 6.24B | 6.33B | 6.44B |
| Retained earnings | 5.80B | 5.84B | 5.91B | 5.77B | 5.83B | 5.90B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 620.00M | 992.00M | 804.00M | 1.07B | 2.13B | 1.71B | 1.47B | 1.06B |
| Depreciation & amortization | 403.00M | 443.00M | 489.00M | 490.00M | 498.00M | 536.00M | 596.00M | 615.00M |
| Free cash flow | 48.00M | 416.00M | 178.00M | 454.00M | 1.38B | 930.00M | 755.00M | 232.00M |
| Dividends paid | -241.00M | -273.00M | -118.00M | -276.00M | -1.17B | -474.00M | -251.00M | -224.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 121.00M | 95.00M | 214.00M | 473.00M | 417.00M | 420.00M | 327.00M | 291.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 165.00M | 269.00M | 308.00M | 314.00M | 195.00M | 290.00M |
| Depreciation & amortization | 151.00M | 150.00M | 157.00M | 157.00M | 160.00M | 167.00M |
| Free cash flow | -25.00M | 67.00M | 128.00M | 62.00M | 60.00M | 93.00M |
| Dividends paid | -52.00M | -55.00M | -55.00M | -62.00M | -60.00M | -69.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 312.00M | 582.00M | 356.00M | 291.00M | 407.00M | 496.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 37.35 | 12.33 | 0.28 | 18.52 | 43.22 | 11.52 | 7.08 | 3.86 |
| ROA %i | 14.18 | 5.29 | 0.12 | 7.55 | 18.91 | 5.54 | 3.55 | 1.90 |
| ROIC %i | 21.61 | 8.68 | 2.01 | 12.00 | 28.24 | 8.69 | 5.88 | 3.53 |
| 5-year avg ROE %i | 15.47 | 15.14 | 11.80 | 16.37 | 22.34 | 17.17 | 16.12 | 16.84 |
| EBIT margin %i | 26.26 | 13.98 | 5.31 | 17.25 | 35.37 | 15.05 | 11.43 | 8.23 |
| FCF / sales %i | 0.86 | 7.89 | 3.53 | 6.53 | 12.76 | 10.81 | 11.04 | 3.24 |
| Current ratioi | 1.39 | 1.52 | 1.31 | 1.50 | 1.75 | 1.53 | 1.54 | 1.33 |
| Quick ratioi | 0.72 | 0.75 | 0.70 | 0.86 | 0.90 | 0.85 | 0.82 | 0.68 |
| Debt / assetsi | 27.63 | 28.36 | 28.27 | 27.19 | 24.03 | 23.11 | 20.25 | 22.20 |
| LT debt / equityi | 48.00 | 55.57 | 52.24 | 53.81 | 42.31 | 31.71 | 33.35 | 31.42 |
| Interest coveragei | 15.36 | 6.76 | 1.22 | 11.11 | 25.67 | 7.09 | 5.36 | 3.98 |
| Revenue CAGR (3Y) %i | 0.92 | -0.58 | -2.36 | 7.77 | 23.86 | 14.33 | -0.55 | -10.61 |
| Net income CAGR (3Y) %i | 34.56 | -- | -68.85 | -14.21 | 65.65 | 288.90 | -19.60 | -52.87 |
| FCF CAGR (3Y) %i | -- | 7.59 | -23.01 | 111.48 | 49.28 | 73.52 | 18.48 | -44.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.70 | 6.24 | 6.15 | 3.86 | 4.39 | 5.02 |
| ROA %i | 3.36 | 3.11 | 3.10 | 1.90 | 2.11 | 2.39 |
| ROIC %i | 5.65 | 5.01 | 5.05 | 3.53 | 3.85 | 4.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.12 | 11.41 | 11.36 | 8.23 | 8.54 | 9.38 |
| FCF / sales %i | 8.48 | 6.85 | 5.03 | 3.24 | 4.28 | 4.45 |
| Current ratioi | 1.47 | 1.75 | 1.43 | 1.33 | 1.38 | 1.58 |
| Quick ratioi | 0.85 | 1.05 | 0.80 | 0.68 | 0.80 | 0.94 |
| Debt / assetsi | 20.75 | 23.56 | 21.86 | 22.20 | 24.21 | 25.00 |
| LT debt / equityi | 31.76 | 42.40 | 30.88 | 31.42 | 36.78 | 43.13 |
| Interest coveragei | 5.16 | 4.24 | 4.33 | 3.98 | 4.31 | 3.99 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Phosphate Solutions is the largest reported line at 33.82% of revenue, across 6 reported segments.
- No single line clears half of revenue; Growing Solutions is next at 28.34%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Phosphate Solutions33.82%
Growing Solutions28.34%
Potash21.92%
Industrial Products19.39%
Other activities2.48%
Quote time 2026-10-08 07:33:43 · For reference only, not investment advice and not tailored to your situation.